Clinical and Cerebral Metabolic Changes in Parkinson's Disease With Basal Forebrain Atrophy

Volume: 35, Issue: 5, Pages: 825 - 832
Published: Jan 23, 2020
Abstract
Background Cholinergic dysfunction plays a key role in cognitive dysfunction in Parkinson's disease (PD). Recent studies revealed that atrophy in the nucleus basalis of Meynert (NBM), the largest cholinergic nucleus in the basal forebrain, heralds cognitive decline in PD. Despite clinical importance of NBM atrophy in PD, clinical and radiological correlates of NBM atrophy remains to be elucidated. Objective We investigated the longitudinal...
Paper Details
Title
Clinical and Cerebral Metabolic Changes in Parkinson's Disease With Basal Forebrain Atrophy
Published Date
Jan 23, 2020
Volume
35
Issue
5
Pages
825 - 832
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.